Jw Pharmac (001060) — Cash Flow Quality Index
Latest as of March 2026:
0.64x
Jw Pharmac (001060) has a Cash Flow Quality Index of 0.64x as of March 2026. Operating cash flow of ₩17.50 Billion is below net income of ₩27.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Jw Pharmac cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.64x
Operating CF / Net Income
Operating Cash Flow
₩17.50 Billion
KRW
Net Income
₩27.48 Billion
KRW
Data as of
Mar 2026
Most recent filing
Jw Pharmac Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Jw Pharmac across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 001060 cash flow conversion.
Annual Cash Flow Quality Index for Jw Pharmac (2001–2025)
Year-by-year earnings quality comparison for Jw Pharmac.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | ₩96.40 Billion | ₩61.51 Billion | ▲ +28.4% |
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | ▼ -118.0% |
| 2014 | 11.80x | ₩7.28 Billion | ₩617.05 Million | ▲ +41.4% |
| 2013 | 8.34x | ₩18.72 Billion | ₩2.24 Billion | ▲ +1814.8% |
| 2006 | 0.44x | ₩5.07 Billion | ₩11.65 Billion | ▼ -94.4% |
| 2005 | 7.74x | ₩70.25 Billion | ₩9.08 Billion | ▲ +548.9% |
| 2004 | 1.19x | ₩15.02 Billion | ₩12.59 Billion | ▼ -25.1% |
| 2003 | 1.59x | ₩17.05 Billion | ₩10.71 Billion | ▼ -39.7% |
| 2002 | 2.64x | ₩28.74 Billion | ₩10.89 Billion | ▼ -39.9% |
| 2001 | 4.39x | ₩45.04 Billion | ₩10.26 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.